Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-29 @ 3:07 AM
Study NCT ID:
NCT05429294
Status:
UNKNOWN
Last Update Posted:
2022-06-23
First Post:
2022-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038
Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
X-XJTU1AFLSY-93
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None